VIKING GLOBAL INVESTORS LP 13D/13G Filings for Athira Pharma, Inc. (ATHA)

VIKING GLOBAL INVESTORS LP 13D and 13G filings for Athira Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-14
5:02 pm
Sale		2021-12-3113GAthira Pharma, Inc.
ATHA		VIKING GLOBAL INVESTORS LP0
0.000%		-2,120,653decrease
(Position Closed)		Filing
2021-02-12
7:55 pm
Unchanged		2020-12-3113GAthira Pharma, Inc.
ATHA		VIKING GLOBAL INVESTORS LP2,120,653
6.000%		0
(Unchanged)		Filing
2020-09-28
5:04 pm
Purchase		2020-09-1813GAthira Pharma, Inc.
ATHA		VIKING GLOBAL INVESTORS LP2,120,653
6.900%		2,120,653increase
(New Position)		Filing